Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 215.82% | 215.81% | -169.55% | -169.49% | -225.07% |
| Total Depreciation and Amortization | 130.68% | 130.81% | 454.07% | 453.97% | 74.07% |
| Total Amortization of Deferred Charges | -131.85% | -131.90% | -- | -- | -- |
| Total Other Non-Cash Items | 45.15% | 45.15% | 689.07% | 688.42% | -252.32% |
| Change in Net Operating Assets | -267.99% | -267.97% | -633.90% | -633.65% | 345.32% |
| Cash from Operations | -265.90% | -265.87% | -2,141.67% | -2,136.25% | 43.61% |
| Capital Expenditure | -1,064.91% | -1,055.65% | -- | -- | -570.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 57.04% | 57.28% | -11.56% | -11.36% | -98.20% |
| Cash from Investing | -126.71% | -126.69% | -66.67% | -66.59% | -88.49% |
| Total Debt Issued | 148.15% | 148.15% | 454.00% | 454.00% | -39.15% |
| Total Debt Repaid | -1,008.11% | -1,008.11% | 13.68% | 13.68% | 87.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -160.25% | -160.25% | -2,193.33% | -2,193.33% | -106.52% |
| Cash from Financing | 5,160.84% | 5,145.99% | 4,769.20% | 4,757.81% | 139.94% |
| Foreign Exchange rate Adjustments | 282.37% | 282.30% | -370.24% | -370.18% | -394.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 202.20% | 202.19% | 21,984.21% | 21,931.58% | -113.99% |